Literature DB >> 18930217

Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.

David B Seifer1, Elizabeth T Golub, Geralyn Lambert-Messerlian, Lorie Benning, Kathryn Anastos, D Heather Watts, Mardge H Cohen, Roksana Karim, Mary A Young, Howard Minkoff, Ruth M Greenblatt.   

Abstract

OBJECTIVE: To compare serum müllerian inhibiting substance (MIS) levels between white, black, and Hispanic women to determine whether ovarian aging occurs at a different time course for women of different racial groups.
DESIGN: Longitudinal study of serum MIS levels in women of different race and ethnicity over two different time points.
SETTING: Women's Interagency HIV Study, a multicenter prospective cohort study. PATIENT(S): Serum samples obtained from 809 participants (122 white, 462 black, and 225 Hispanic women). INTERVENTION(S): Comparison of serum MIS between women of different race and ethnicity at two time points (median age 37.5 years and 43.3 years). MAIN OUTCOME MEASURE(S): Variation in MIS by race and ethnicity over time, controlling for age, body mass index, HIV status, and smoking. RESULT(S): Compared with white women, average MIS values were lower among black (25.2% lower) and Hispanic (24.6% lower) women, adjusting for age, body mass index, smoking, and HIV status. CONCLUSION(S): There is an independent effect of race and ethnicity on the age-related decline in MIS over time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930217      PMCID: PMC3037722          DOI: 10.1016/j.fertnstert.2008.08.110

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  22 in total

1.  Measures of menopausal status in relation to demographic, reproductive, and behavioral characteristics in a population-based study of women aged 35-49 years.

Authors:  G S Cooper; D D Baird; F R Darden
Journal:  Am J Epidemiol       Date:  2001-06-15       Impact factor: 4.897

2.  Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.

Authors:  Antonio La Marca; Stefania Malmusi; Simone Giulini; Leo Fischer Tamaro; Raoul Orvieto; Paola Levratti; Annibale Volpe
Journal:  Hum Reprod       Date:  2004-09-30       Impact factor: 6.918

3.  Comparison of implantation and pregnancy rates in African American and white women in an assisted reproductive technology practice.

Authors:  J E Nichols; H L Higdon; M M Crane; W R Boone
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

4.  Prospective study of the determinants of age at menopause.

Authors:  J T Bromberger; K A Matthews; L H Kuller; R R Wing; E N Meilahn; P Plantinga
Journal:  Am J Epidemiol       Date:  1997-01-15       Impact factor: 4.897

5.  Serum müllerian-inhibiting substance levels during normal menstrual cycles.

Authors:  C L Cook; Y Siow; S Taylor; M E Fallat
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

6.  Factors influencing the age at natural menopause.

Authors:  J L Stanford; P Hartge; L A Brinton; R N Hoover; R Brookmeyer
Journal:  J Chronic Dis       Date:  1987

7.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

8.  Disparity in assisted reproductive technologies outcomes in black women compared with white women.

Authors:  David B Seifer; Linda M Frazier; David A Grainger
Journal:  Fertil Steril       Date:  2007-11-05       Impact factor: 7.329

9.  Mixed models for longitudinal left-censored repeated measures.

Authors:  Rodolphe Thiébaut; Hélène Jacqmin-Gadda
Journal:  Comput Methods Programs Biomed       Date:  2004-06       Impact factor: 5.428

10.  Premature menopause in a multi-ethnic population study of the menopause transition.

Authors:  J L Luborsky; P Meyer; M F Sowers; E B Gold; N Santoro
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  36 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

3.  Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women.

Authors:  E E Marsh; N D Shaw; K M Klingman; T O Tiamfook-Morgan; M A Yialamas; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

4.  Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women.

Authors:  Rebecca Scherzer; Peter Bacchetti; Geralyn Messerlian; Johanna Goderre; Pauline M Maki; David B Seifer; Kathryn Anastos; Roksana Karim; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2014-10-23       Impact factor: 3.886

5.  Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.

Authors:  Vicky Moy; Sangita Jindal; Harry Lieman; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2015-07-21       Impact factor: 3.412

6.  Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore.

Authors:  Ryan Wai Kheong Lee; Lay Wai Khin; Marianne Sybille Hendricks; Heng Hao Tan; Sadhana Nadarajah; Nancy Wen Sim Tee; Seong-Feei Loh; Bee Choo Tai; Jerry Ky Chan
Journal:  Singapore Med J       Date:  2020-09       Impact factor: 1.858

7.  First assessment of menstrual cycle function and reproductive endocrine status in Samoan women.

Authors:  G Lambert-Messerlian; M B Roberts; S S Urlacher; J Ah-Ching; S Viali; M Urbanek; S T McGarvey
Journal:  Hum Reprod       Date:  2011-06-15       Impact factor: 6.918

8.  The effect of endometriosis on the antimüllerian hormone level in the infertile population.

Authors:  Phillip A Romanski; Paula C Brady; Leslie V Farland; Ann M Thomas; Mark D Hornstein
Journal:  J Assist Reprod Genet       Date:  2019-04-16       Impact factor: 3.412

9.  Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.

Authors:  Pierre Lehmann; Maria P Vélez; Julio Saumet; Louise Lapensée; Wael Jamal; François Bissonnette; Simon Phillips; Isaac-Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2014-02-27       Impact factor: 3.412

10.  Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?

Authors:  Maria E Bleil; Steven E Gregorich; Daniel McConnell; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2013-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.